Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – African Americans are less likely to develop atrial fibrillation after isolated coronary artery bypass graft (CABG) surgery than European Americans, a new study…
NEW YORK (Reuters Health) – When performed at centers of excellence, robotic partial nephrectomy (RPN) has “an acceptably low” complication rate that mirrors that of open partial nephrectomy…
NEW YORK (Reuters Health) – Metformin beginning at the age of 8 years in girls at risk of polycystic ovary syndrome (PCOS) is more effective than a later…
NEW YORK (Reuters Health) – After six monthly intraocular injections of ranibizumab (Lucentis; Genentech) for macular edema, the benefits are maintained for another 6 months when ranibizumab is…
NEW YORK (Reuters Health) – When oral administration of midazolam is problematic for sedating children undergoing laceration repair, intranasal or buccal delivery via aerosol is a useful alternative,…
NEW YORK (Reuters Health) – Retinal videos are just as effective as standard still retinal images for detecting diabetic retinopathy, according to results of a comparative study of…
NEW YORK (Reuters Health) – Women with a singleton pregnancy and a prior preterm birth can be safely monitored with transvaginal ultrasound cervical length screening as opposed to…
NEW YORK (Reuters Health) – Ambulatory blood pressure monitoring (ABPM) is a better predictor of renal and cardiovascular events than office BP measurement in patients with chronic kidney…
NEW YORK (Reuters Health) – Patients with unprotected left main disease and right coronary artery chronic total occlusion (CTO) undergoing percutaneous coronary intervention (PCI) face an increased risk…
NEW YORK (Reuters Health) – Besides preventing HIV-1 mother-to-child transmission (PMTCT), triple antiretroviral therapy during pregnancy improves pregnancy outcomes, according to findings published in the June 6th online…
